Polymedication and inadequate medication in the elderly;Polymedication et medication inadequate chez la personne agee

Revue de Geriatrie

Volumn 23, Issue 8, 1998, Pages 681-684,686

  Kergoat, M J ^a   Champoux, N ^a  

^a CENTRE DE RECHERCHE   (Canada)

Author keywords

Aging; Drug misuse; Polypharmacy

Indexed keywords

ARTICLE; COMORBIDITY; DRUG MISUSE; GERIATRIC CARE; HUMAN; MEDICAL LITERATURE; PHYSICIAN; POLYPHARMACY; PRESCRIPTION; STATISTICAL ANALYSIS;

EID: 7844237874     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. KROENKE K., Polypharmacy: Causes, consequences and care. Am. J.Med. 1985. 79 149-152.
2. UNITED STATES PUBUC HEALTH SERVICE.: Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: U.S. Department of Health and Human Services. Public Health Service DHHS Publication (PHS) 91-50212 ,1991.
3. KRUSE W., RAMPMAER J., FRAUENRATH-VOLKERS C. et al.: Drugprescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older. Eur. J. Clin. Pharmacol. 1991: 41: 441-447.
4. BEERS M.H., OUSLANDER J.G. Risk factors in geriatric drug prescribing: A practical guide to avoiding problems Drugs 1989; 37: 105-112.
5. MONTAMAT S C., CUSACK B.: Overcoming problems with polypharmacy and drug misuse in the elderly. Clin. Geriatr. Med. 1992; 8: 143-157.
6. NOBERT Y., ASSELIN S., DUCHESNE L. et al. Les conditions de vie au Québec: un portrait statistique. Bureau de la Statistique du Québec, Québec, 1996.
7. FOURRIER A., LETENNEUR L , DARTIGUES J .,DECAMP A., BÉGAUD B : Consommation medicamenteuse chez le sujet âgé vivant à domicile et en institution à partir de la cohorte PAQUID: Importance de la polymédication et utilisation des psychotropes. Rev Gériatr.1996; 21 (7): 473-482.
8. STEWART R B , MARKS R.G., MAY FE., HALE W.E.: Factors which predict multiple drug use in the elderly. J Geriatr Drug Ther 1994; 9: 53-67.
9. GURWITZ J.H., AVORN J : The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991: 114: 956-966.
10. BELLEROSE C., LAVALLÉE C., CHENARD L., LEVASSEUR M.: Et la santé, ça va en 1992-1993 ? Rapport de l'enquête sociale et de santé 1992-1993. Vol 1 Santé Québec. Ministère de la santé et des services sociaux, Gouvernement du Québec. Québec, 1995.
11. GOUERNEMENT DU QUÉBEC : Statistiques annuelles 1991. Québec, Régie de l'assurance-maladie du Québec, 1991.
12. JEANDEL C , GRAILLE M , FERRY J.C.: La prescription médicamenteuse chez la personne âgée. A propos d'une enquête dans la région Nord-Est. Rev. Gériatr 1996; 21(7). 483-488.
13. Rapport du comité d'analyse de la consommation médicamenteuse des personnes âgées. Régie de l'assurance-maladie du Québec, Québec, 1992.
14. LEXCHIN J : Adverse drug reactions. Review of the Canadian Literature. Can. Fam. Phys 1991. 37: 109-118.
15. GRYMONPRE R E , MITENKO P A., SITAR D.S , AOKI F Y., MONTGOMERY P.R., Drug-associated hospital admissions in older medicaid patients. J Am Genatr Soc. 1988; 36: 1092-1098
16. POPPLEWELL P Y , HENSCHKE R J Acute admissions to a geriatric assessment unit. Med J Aust 1982; 1: 343-344
17. HANLON J T , SCHMADER K E. SAMSA G.P et al A method for assessing drug rherapy appropriateness J Clin. Epidemil. 1992: 45 1045-1051
18. SAMSA G P , HANLON J.T . SCHMADER K.E. et al.: A summated score for the medication appropriateness index : Development and assessment of clinimetric properties including content validity. J Clin. Epidemiol. 1994; 47-891-896
19. BERNSTEIN L.R , FOLKMAN S., LAZARUS R.S.: Characterization of the use and misuse of medications by an elderly, ambulatory population. Med. Care 1989: 27. 654-663.
20. BEERS M.H., OUSLANDER J.,G., ROLLINGHER I. et al.: Explicit criteria for determining inappropriate medication use in nursing home residents. Arch. Intern. Med. 1991; 151: 1825-1830.
21. LIPTON H.L., BERO L.A., BIRD J.A., MCPHEE S.J.: The impact of clinical pharmacists' consultations on physicians' genatric drug prescribing. Med. Care 1992; 30: 646-658.
22. MCLEOD P.J , HUANG A.R., TAMBLYN R.M., GAYTON D.C.: Defining inappropriate practices in prescnbing for elderly people: A national consensus panel. Can. Med. Assoc. J. 1997; 156: 385-391.
23. HANSTEN P D , HORN J.R.: The top 40 drug interactions. Drug interactions Newsletter 1991; 11: 483-490
24. NOLAN L., O'MALLEY K.: Prescribing for the elderly: part I: Sensitivity of the elderly to adverse drug reactions. J. Am. Geriatr. Soc. 1988; 36: 142149.
25. HURWITZ N . Predisposing factors in adverse reaction to drugs. Br. Med. J. 1969; 1: 536-539.
26. NOLAN L., O'MALLEY K.: Adverse drug reactions in the elderly. Br. J. Hosp. Med. 1989; 41: 446-457.
27. FERRY M.: Nutrition de la personne âgée. Aspects fondamentaux, cliniques et psychosociaux. Berger-Levrault Ed. Paris, 1996; 119.
28. MANCIAUX M.A.: Thrapeutiques médicamenteuses en gériatrie. Masson Ed. Paris, 1993; 33.
29. BUFFET., PELLETIER G : Hépathologie. Masson Ed. Paris, 1994; 88.
30. GRAND A., FERRY M.: Médicaments cardiologiques et sujets âgés. De la pharmacologie à l'ordonnance MEDSI/ McGraw-Hill Ed. Paris, 1989; 9.
31. COCKCROFT D.W., GAULT M.H.: Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 16: 31-41.
32. WOLF P A., ABBOTT R.D., KANNEL W B Atrial fibrillation: a major contributor to stroke in the elderly. Arch. Intern Med. 1987; 147: 1561-1564.
33. STROKE PREVENTION IN ATRIAL FIBRILLATION INVESTIGATORS.: Adjusteddose warfarin versus low-intensity, fixed-dose warfann plus aspirin for high risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation m randomized clinical trial. Lancet 1996; 348 633-638.
34. PETERSON B., BOYSEN G , GODFERTSON J et coll.: Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989; 1: 175-179.
35. DAHLOF B et coll.: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension Lancet 1991; 338: 1281-1285.
36. THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM (SHEP) COOPERATIVE RESEARCH GROUP.: Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: final results of SHEP. JAMA 1991; 265. 3255-3264.